Prior research has found that exposure to social diversity in early life, such as through day care, influences how people communicate.
OSE wins French govt grant for Phase III trial for cancer vaccine
Share this article The US Food and Drug Administration (FDA) approved the trial protocol for the registrational Phase III trial for OSE’s Tedopi in January.